There is a selective and significant neuron-specific reduction in PP2A catalytic subunit and PP2A regulatory B subunit mRNAs in AD hippocampus [3,4], and this reduced neuronal PP2A immunoreactivity closely correlates with NFT load [4], suggesting that PP2A dysfunction contributes to AD tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.